Shield Therapeutics Share Discussion Threads

[skcots48] 25/9/2023 10:06

Great to see this above 12p and at least doubling the stock I got at 6p. Still down overall and trying to remain patient. Getting there though

[best1467] 25/9/2023 10:04

Strong rise as the chart indicators on the neck line break.
With anything positive not expected in the results this could move very quickly with the break of 13 hopefully holding

[tripletop1] 25/9/2023 09:39

No doubt this will now pull in the breakout traders.. chart could not look any better as it stands

[parob] 25/9/2023 09:27

This was from Finncap in July so not sure if they've updated since then. TP 59p.Encouraging Q2/H1 business updateShield Therapeutics provided a reassuring business update covering recent developments, including strong Q2 2023 US Accrufer® prescription growth (+50% on Q1) and 157% increase in new prescribers in Q2 vs Q1, with early signs of the impact of the enlarged sales force on Accrufer prescriptions clearly evident and yet to become fully productive. Highly encouraging also is the fact that 73% of prescribers in Q1 wrote a repeat Rx in Q2, which supports the notion that once the newly trained sales team is fully up to speed and driving awareness amongst the targeted 12,000+high prescribers, prescription growth should ramp significantly. Whilst revenues are skewed heavily to H2, the early KPIs put Shield on track to meet its 2023 target for US Accrufer® prescriptions (125-160,000). We leave forecasts unchanged but adjust our DCF-derived target price to 59p to reflect the dilution from the AOP debt-to-equity conversion (713m shares vs. 586m).Mark Brewer

[cyberbub] 25/9/2023 09:25

Good to see a first break of 12p! Hopefully it will hold. Results on Thursday, not entirely clear whether they will provide a Q3 update. I originally thought they would, but I now suspect they might leave it until they have a confirmed September figure, perhaps in mid-Oct. So it's either 3 days or 3 weeks until we see whether our confidence was correct!!

[parob] 25/9/2023 09:12

As I reminder, as far as l'm aware this is the latest from Hardman. Current target price of 48p. Shield is a commercial-stage pharma company delivering specialty products that address patients' unmet medical needs, with an initial focus on iron deficiency (ID). Since its US launch in July 2021, Shield has been increasing physician awareness of the differentiating characteristics of Accrufer® as an oral ID drug, with the aim of ramping up prescription (Rx) growth and sales traction. Positive Rx momentum in 2022 started to accelerate at the end of 1Q'23 and has continued into 2Q'23, following expansion of the Shield-Viatris commercial team. In the event that the US goals are achieved, there would be CONSIDERABLE UPSIDE POTENTIAL TO THE VALUATION. They have up-to-date target at 48p.

[devonlad] 25/9/2023 09:03

Nice growth path! Thanks!

[little minx] 25/9/2023 08:53

Another go at 12p

[zeus19] 25/9/2023 08:26

openprescribing.net/chemical/0901011Y0/

[purchaseatthetop] 25/9/2023 08:21

I added today. Having been in STX well before it got FDA approval it is nice to watch it finally rise and have a solid flight path ahead.

[2theduke] 25/9/2023 08:14

Hi jimbren , do you have a link to tthat nhs data ? Gla this week, it will be interesting

[quantas01] 22/9/2023 15:35

God help us if the Convicted Charity Thief has found his way here. It was only two minutes ago he was saying all his money was going into ENET which is in the last throws of a death twitch.

[heatseek77] 22/9/2023 10:30

Fester gives you something to do rather than walk up and down the hill 😂🤣

[purchaseatthetop] 22/9/2023 10:27

Blimey. All those are me! I am busy. Keep it up. Or you could talk about the share. Up to you.

[heatseek77] 22/9/2023 10:25

Scuba pat kiss of death 🤣

Apparently pat is all these too

Purchaseatthetop. SEAGREEN. Davethechef. Markliddiard. Papillon. 504. BSG. Coeun. Penstocks. Sirmark. Unionhall. Howdlep. Bad gateway. Festario. Goforgold1. Jailbird.

[scubadiverr] 22/9/2023 09:54

Oh fwck, you're the kiss of death. I won't ask as to whether it is your money or the charity's money to which you refer.

[purchaseatthetop] 22/9/2023 09:47

I added again first thing today. This is where my money in now going. Get prepared for it to crash again. Actually the cash flow looks fine so I think it is going one way over the next two years. I bought back in at 7.3p so averaging up.

[2theduke] 22/9/2023 08:39

There isn’t any stock to buy, unless someone can tell me otherwise ?

[best1467] 22/9/2023 07:10

Chart looking good Reverse head/shoulders a break on the neckline would be a positive today for the Chartist investors